✦ LIBER ✦

324 CG100649, A TISSUE-SPECIFIC DUAL INHIBITOR OF COX-2 AND CARBONIC ANHYDRASE: PHASE 2A CLINICAL TRIAL IN HIP & KNEE OSTEOARTHRITIS

✍ Scribed by W.K. Schmidt; K. Lehnhardt; J. Hettwer; O. Nadashkevich; I. Szombati; V. Povoroznyuk; B. Chung; H.S. Nam; S.S. Cho; S. Ro; J.M. Cho

Book ID: 114351535
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 43 KB
Volume: 17
Category: Article
ISSN: 1063-4584
DOI: 10.1016/s1063-4584(09)60346-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

(234) CG100649, a novel dual-acting COX-

(234) CG100649, a novel dual-acting COX-2 and carbonic anhydrase inhibitor: Multi-dose pharmacokinetics and safety evaluation in healthy male and female subjects

✍ W. Schmidt; B. Chung; K. Fong; S. Swan; C. Cannon; H. Alcorn; H. Liang; Y. Zhu; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB

(232) CG100649, a novel dual-acting COX-

(232) CG100649, a novel dual-acting COX-2 and carbonic anhydrase inhibitor: Ascending single dose and multi-dose pharmacokinetics and safety evaluation in healthy male subjects

✍ S. Ro; Y. Park; T. Mant; W. Schmidt; M. Kang; J. Cho 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 42 KB

Rofecoxib, a specific inhibitor of cyclo

Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: Results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip

✍ Grant W. Cannon; Jacques R. Caldwell; Peter Holt; Barry McLean; Beth Seidenberg; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 3 views